We are live on
!
Find out more
O
OrbiMed Portfolio holdings
AUM
$4.59B
1-Year Est. Return
125.28%
This Fund
S&P 500
This Quarter
Est. Return
+7.88%
1 Year Est. Return
+125.28%
3 Year Est. Return
+334.72%
5 Year Est. Return
+344.07%
10 Year Est. Return
+2,748.76%
AUM
$3.98B
AUM Growth
-$187M
(-4.5%)
Cap. Flow
-$236M
Cap. Flow
% of AUM
-5.94%
Top 10 Holdings %
Top 10 Hldgs %
49.18%
Holding
122
New
13
Increased
19
Reduced
24
Closed
22
Top Buys
| 1 |
CAI
Caris Life Sciences
CAI
|
+$81.8M |
| 2 |
UnitedHealth
UNH
|
+$51.6M |
| 3 |
Roivant Sciences
ROIV
|
+$30.1M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
+$23.2M |
| 5 |
JBIO
Jade Biosciences
JBIO
|
+$18.1M |
Top Sells
| 1 |
Pfizer
PFE
|
+$97.6M |
| 2 |
Ionis Pharmaceuticals
IONS
|
+$76.6M |
| 3 |
Neurocrine Biosciences
NBIX
|
+$56.9M |
| 4 |
SWTX
SpringWorks Therapeutics
SWTX
|
+$41.9M |
| 5 |
Thermo Fisher Scientific
TMO
|
+$34.5M |
Sector Composition
| 1 | Healthcare | 99.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RAPT
51
DELISTED
RAPT Therapeutics
RAPT
| $13.1M | 0.33% |
1,641,906
-2
| -0% | -$15 |
|
|
FOLD
52
DELISTED
Amicus Therapeutics
FOLD
| $13.1M | 0.33% |
2,285,400
| – | – |
|
53
Vir Biotechnology
VIR
$1.62B
| $12M | 0.3% |
2,380,715
+132,466
| +6% | +$710K |
|
54
AbCellera Biologics
ABCL
$2.09B
| $11.5M | 0.29% |
3,344,568
-836,200
| -20% | -$2.08M |
|
|
AKRO
55
DELISTED
Akero Therapeutics
AKRO
| $11.3M | 0.28% |
211,300
+31,400
| +17% | +$1.43M |
|
56
Mineralys Therapeutics
MLYS
$2.38B
| $10.3M | 0.26% |
+760,351
| New | +$11M |
|
57
Dyne Therapeutics
DYN
$3.91B
| $9.82M | 0.25% |
1,031,400
+16,789
| +2% | +$185K |
|
58
C4 Therapeutics
CCCC
$412M
| $9.77M | 0.25% |
6,830,300
| – | – |
|
59
Oric Pharmaceuticals
ORIC
$1.11B
| $9.13M | 0.23% |
899,281
+199,281
| +28% | +$1.34M |
|
60
Catalyst Pharmaceutical
CPRX
$3.85B
| $9.05M | 0.23% |
+416,900
| New | +$9.84M |
|
61
Prelude Therapeutics
PRLD
$352M
| $8.83M | 0.22% |
10,909,256
| – | – |
|
62
Corbus Pharmaceuticals
CRBP
$165M
| $8.09M | 0.2% |
1,172,287
| – | – |
|
63
Zai Lab
ZLAB
$2.3B
| $8.08M | 0.2% |
+231,000
| New | +$7.59M |
|
64
Tarsus Pharmaceuticals
TARS
$2.41B
| $8.02M | 0.2% |
197,900
-455,843
| -70% | -$20.5M |
|
|
WHWK
65
Whitehawk Therapeutics
WHWK
$190M
| $7.79M | 0.2% |
4,166,000
| – | – |
|
66
Tyra Biosciences
TYRA
$1.9B
| $7.7M | 0.19% |
804,603
-948,228
| -54% | -$9.01M |
|
67
Adicet Bio
ACET
$81M
| $6.98M | 0.18% |
715,446
| – | – |
|
|
ITOS
68
DELISTED
iTeos Therapeutics
ITOS
| $6.98M | 0.18% |
+700,000
| New | +$5.64M |
|
69
PMV Pharmaceuticals
PMVP
$76.3M
| $6.86M | 0.17% |
6,475,291
| – | – |
|
70
UroGen Pharma
URGN
$1.94B
| $6.55M | 0.16% |
+478,400
| New | +$4.59M |
|
71
Ascendis Pharma A/S
ASND
$17.5B
| $5.94M | 0.15% |
+34,400
| New | +$5.6M |
|
|
ALMS
72
Alumis Inc
ALMS
$3.44B
| $5.78M | 0.15% |
+1,926,423
| New | +$9.1M |
|
|
JBIO
73
Jade Biosciences
JBIO
$1.3B
| $5.31M | 0.13% |
+531,163
| New | +$18.1M |
|
74
InspireMD
NSPR
$33.7M
| $4.84M | 0.12% |
2,133,405
| – | – |
|
75
Avalo Therapeutics
AVTX
$971M
| $4.83M | 0.12% |
967,000
| – | – |
|
Similar funds
CGI
LNWTC
SCM
AG
SCM
SV
ANTB
ECM